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Introduction
Hypericin is a substance isolated from a medicinal herb Hypericum perforatum, commonly known as St.John’s Wort.1
Hypericin belongs to group of compound known as napthodianthrones. 2 Hypericin is a secondary plant metabolite of
St.John’s Wort and the amount of Hypericin strongly depend upon the source of the plant material. 3,4 Initially
Hypericin was considered to be the antidepressant principle of Hypericum perforatum, but according to latest research
Hyperforin has emerged as antidepressant principle of the herb.5 Hypericin is used as standard for identification of
genuine plant material and thus has importance from quality control point of view. The standardization of Hypericum
perforatum is now based on both hypericin and hyperforin content. The herb must contain 0.3% of hypericin.
 
Chemistry
Hypericin is a red dye that forms salt known as hypercinates with sodium and potassium. It is soluble in ethanol,
methanol, pyridine, acetone, ethyl acetate, butanone, aqueous alkali solutions, but insoluble in water and methylene
chloride. 7 Hypericin produces singlet oxygen and other excited state intermediates that indicate it should be a very
efficient phototoxic agent in the eye. It absorbs in the UV and visible range, which means it, can potentially damage
both the lens and the retina. Hypericum perforatum is known to cause photosensitivity.8 
 
Pharmacological activity
 A. Antidepressant activity 
In experiments, hypericin has shown weak monoamine oxidase inhibiting activity. It was find that hypercin in a dose
of 0.35 mg has effects similar to imipramine. 9 In other experiment hypericin in a dose of 9-28 mg/kg showed activity
similar to bupropion. 10 Hyperforin in comparison inhibits the neuronal uptake of serotonin, norepinephrine and
dopamine antidepressants, but also inhibits GABA and L-glutamate uptake.11 Research on hyperforin has been
intensified and most of the published studies strongly indicate hyperforin to be the antidepressant constituent of
Hypericum perforatum. 12,13,14
 
B. Anti viral activity
In animal models hypericin has shown to prevent replication of encapsulated viruses.15
 
C. Anti-inflammatory activity 
Besides these activities, hypericin has shown anti-inflammatory activity also. It inhibits release of leukotrienes.16
 
 D. Photosensitizing activity   
Hypericin is known to cause phototoxicity. Lens alpha-crystallin, isolated from calf lenses, was irradiated in the
17
presence of hypericin and in the presence and absence of light.  Hypericin-induced photosensitized photo-
polymerization was assessed by sodium dodecylsulfate-polyacrylamide gel electrophoresis. Further analysis of the
oxidative changes occurring in alpha-crystallin using mass spectrometry showed specific oxidation of methionine,
tryptophan and histidine residues, which increased with irradiation time. Hypericin did not damage the lens protein in
the dark. Damage to alpha-crystallin could undermine the integrity of the lens directly by protein denaturation and
indirectly by disturbing chaperone function. From the study it was concluded that in the presence of light, hypericin
could induce changes in lens protein that could lead to the formation of cataracts. Appropriate precautions should be
taken to protect the eye from intense sunlight while the patient is on Hypericum perforatum therapy.
  
Pharmacokinetics 
In a study, healthy volunteers were given hypercin orally in a dose of 900, 1800 and 3600 mg and blood samples were
analyzed.The maximum plasma concentration was found after 6 hours.18
 
Standard
The hypericin content of Hypericum perforatum is determined by using spectroscopic method utilizing the visible
absorption characteristics of hypericin in methyl alcohol.19, 20 In atypical chromatogram of standardized Hypericum
perforatum extract, absorbance occurs at 588nm and the peak.The peak at 10.67 min is characteristic of Hypericin.
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